The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia: A Randomized Controlled Trial
Abstract
CONTEXT: Children with familial hypercholesterolemia have endothelial dysfunction and increased carotid intima-media thickness (IMT), which herald the premature atherosclerotic disease they develop later in life. Although intervention therapy in the causal pathway of this disorder has been available for more than a decade, the long-term efficacy and safety of cholesterol-lowering medication have not been evaluated in children. OBJECTIVE: To determine the 2-year efficacy and safety of pravastatin therapy in children with familial hypercholesterolemia. DESIGN: Randomized, double-blind, placebo-controlled trial that recruited children between December 7, 1997, and October 4, 1999, and followed them up for 2 years. SETTING AND PARTICIPANTS: Two hundred fourteen children with familial hypercholesterolemia, aged 8 to 18 years and recruited from an academic medical referral center in the Netherlands. INTERVENTION: After initiation of a fat-restricted diet and encouragement of regular physical activity, children were randomly assigned to receive treatment with pravastatin, 20 to 40 mg/d (n = 106), or a placebo tablet (n = 108). MAIN OUTCOME MEASURES: The primary efficacy outcome was the change from baseline in mean carotid IMT compared between the 2 groups over 2 years; the principal safety outcomes were growth, maturation, and hormone level measurements over 2 years as well as changes in muscle and liver enzyme levels. RESULTS: Compared with baseline, carotid IMT showed a trend toward regression with pravastatin (mean [SD], -0.010 [0.048] mm; P =.049), whereas a trend toward progression was observed in the placebo group (mean [SD], +0.005 [0.044] mm; P =.28). The mean (SD) change in IMT compared between the 2 groups (0.014 [0.046] mm) was significant (P =.02). Also, pravastatin significantly reduced mean low-density lipoprotein cholesterol levels compared with placebo (-24.1% vs +0.3%, respectively; P<.001). No differences were observed for growth, muscle or liver enzymes, endocrine function parameters, Tanner staging scores, onset of menses, or testicular volume between the 2 groups. CONCLUSION: Two years of pravastatin therapy induced a significant regression of carotid atherosclerosis in children with familial hypercholesterolemia, with no adverse effects on growth, sexual maturation, hormone levels, or liver or muscle tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Chambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Haycock, G. B., Schwartz, G. J., & Wisotsky, D. H. (1978) · The Journal of Pediatrics · doi:10.1016/s0022-3476(78)80601-5 · Cited by 1,675
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Hodis, H. N., Mack, W. J., LaBree, L., Selzer, R. H., Liu, C.-R., Liu, C.-H., & Azen, S. P. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-4-199802150-00002 · Cited by 1,217
Smilde, T., van Wissen, S., Awollersheim, H., Trip, M., Kastelein, J., & Stalenhoef, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04053-8 · Cited by 918
Self-citationWarnick, G. R., Knopp, R. H., Fitzpatrick, V, & Branson, L. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.1.15 · Cited by 567
Järvisalo, M. J., Jartti, L., Näntö-Salonen, K., Irjala, K., Rönnemaa, T., Hartiala, J. J., Celermajer, D. S., & Raitakari, O. T. (2001) · Circulation · doi:10.1161/hc4901.100522 · Cited by 491
Early statin therapy restores endothelial function in children with familial hypercholesterolemia
de Jongh, S., Lilien, M. R., op’t Roodt, J., Stroes, E. S. G., Bakker, H. D., & Kastelein, J. J. P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02593-7 · Cited by 367
Self-citationArterial intima-media thickness in children heterozygous for familial hypercholesterolaemia
Wiegman, A., de Groot, E., Hutten, B. A., Rodenburg, J., Gort, J., Bakker, H. D., Sijbrands, E. J., & Kastelein, J. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15467-6 · Cited by 324
Self-citationde Jongh, S., Ose, L., Szamosi, T., Gagné, C., Lambert, M., Scott, R., Perron, P., Dobbelaere, D., Saborio, M., Tuohy, M. B., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035247.42888.82 · Cited by 308
Self-citationStein, E. A., Illingworth, D. R., Kwiterovich, Jr., Liacouras, C. A., Siimes, M. A., Jacobson, M. S., Brewster, T. G., Hopkins, P., Davidson, M., Graham, K., et al. (1999) · JAMA · doi:10.1001/jama.281.2.137 · Cited by 270
Development of coronary heart disease in familial hypercholesterolemia.
Mabuchi, H., Koizumi, J., Shimizu, M., & Takeda, R. (1989) · Circulation · doi:10.1161/01.cir.79.2.225 · Cited by 244
The molecular basis of familial hypercholesterolemia in The Netherlands
Fouchier, S. W., Defesche, J. C., Umans-Eckenhausen, M. A., & Kastelein, J. J. (2001) · Human Genetics · doi:10.1007/s00439-001-0628-8 · Cited by 203
Self-citationvan Dam, M. J., de Groot, E., Clee, S. M., Hovingh, G. K., Roelants, R., Brooks-Wilson, A., Zwinderman, A. H., Smit, A. J., Smelt, A. H., Groen, A. K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07277-x · Cited by 198
Self-citationKwiterovich, P. O., Fredrickson, D. S., & Levy, R. I. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107670 · Cited by 191
Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia
Knipscheer, H. C., Boelen, C. C. A., Kastelein, J. J. P., Van Diermen, D. E., Groenemeijer, B. E., Van Den Ende, A., Büller, H. R., & Bakker, H. D. (1996) · Pediatric Research · doi:10.1203/00006450-199605000-00021 · Cited by 166
Self-citationIncreased intima-media thickness of the common carotid artery in hypercholesterolemic children.
Pauciullo, P., Iannuzzi, A., Sartorio, R., Irace, C., Covetti, G., Costanzo, A. D., & Rubba, P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1075 · Cited by 160
Treatment of Familial Hypercholesterolemia in Children and Adolescents: Effect of Lovastatin
Lambert, M. A., Lupien, P.-J., Gagné, C., Levy, E. H., Blaichman, S., Langlois, S., Hayden, M. R., Rose, V., Clarke, J. T. R., Wolfe, B. M. J., et al. (1996) · PEDIATRICS · doi:10.1542/peds.97.5.619 · Cited by 158
NEONATAL DIAGNOSIS OF FAMILIAL TYPE-II HYPERLIPOPROTEINÆMIA
Kwiterovich, P., Levy, R., & Fredrickson, D. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90194-3 · Cited by 154
Family History and Cardiovascular Risk in Familial Hypercholesterolemia
Wiegman, A., Rodenburg, J., de Jongh, S., Defesche, J. C., Bakker, H. D., Kastelein, J. J. P., & Sijbrands, E. J. G. (2003) · Circulation · doi:10.1161/01.cir.0000058166.99182.54 · Cited by 142
Self-citationde Jongh, S., Liliën, M. R., Bakker, H. D., Hutten, B. A., Kastelein, J. J. P., & Stroes, E. S. G. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00003-5 · Cited by 133
Self-citationIndications for low-density lipoprotein apheresis
Gordon, B. R., Stein, E. A., Jones, P. J. H., & Illingworth, D. R. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90461-8 · Cited by 52
Mouratidis, B., Vaughan-Neil, E. F., Gilday, D. L., Ash, J. M., Cullen-Dean, G., McIntyre, S. E., MacMillan, J. H., & Rose, V. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90038-z · Cited by 41
Targeting High-Risk Young Patients for Statin Therapy
Gotto, A. M. (2004) · JAMA · doi:10.1001/jama.292.3.377 · Cited by 7
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
McCrindle, B. W., Rowley, A. H., Newburger, J. W., Burns, J. C., Bolger, A. F., Gewitz, M., Baker, A. L., Jackson, M. A., Takahashi, M., Shah, P. B., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000484 · Cited by 3,723
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Metadata
- Authors
- Wiegman, A., Hutten, B. A., de Groot, E., Rodenburg, J., Bakker, H. D., Büller, H. R., Sijbrands, E. J. G., & Kastelein, J. J. P.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2004-07-21
- Volume
- 292
- Issue
- 3
- Pages
- 331
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2161453510
- Cited by
- 649
- References
- 24
- FWCI
- 33.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.